https://www.indianpharmapost.com/bristol-myers-squibb-and-cellares-inks-us-380-million-capacity-reservation-for-the-manufacture-of-car-t-cell-therapies-155592024-04-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/abbvies-phase-3-select-gca-study-of-upadacitinib-showed-positive-results-in-patients-with-giant-cell-arteritis-155602024-04-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/voydeya-approved-in-the-eu-as-add-on-treatment-to-ravulizumab-155612024-04-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/zydus-new-drug-application-of-desidustat-tablets-accepted-by-china-medical-system-holdings-155622024-04-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/kwality-pharmaceuticals-receives-approval-from-invima-for-ampoule-and-vial-product-lines-155632024-04-23T00:00:00+05:30always0.9